{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:12:14Z","timestamp":1775650334588,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011338","name":"AstraZeneca Schweiz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01449-w","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:50:02Z","timestamp":1772538602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic effects following initiation of single-inhaler triple therapy in COPD: a prospective observational study"],"prefix":"10.1186","volume":"32","author":[{"given":"Noriane A.","family":"Sievi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego M.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Herth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Ser\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Roeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvan","family":"Vesenbeckh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian F.","family":"Clarenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"1449_CR1","doi-asserted-by":"publisher","unstructured":"Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance. Chest. 2008;134(2):394\u2013401. https:\/\/doi.org\/10.1378\/chest.08-0440.","DOI":"10.1378\/chest.08-0440"},{"key":"1449_CR2","doi-asserted-by":"publisher","unstructured":"Aqeel A, Akram A, Ali M, Iqbal M, Aslam M, Rukhma, et al. Mechanistic insights into impaired beta-oxidation and its role in mitochondrial dysfunction: a comprehensive review. Diabetes Res Clin Pract. 2025;223:112129. https:\/\/doi.org\/10.1016\/j.diabres.2025.112129.","DOI":"10.1016\/j.diabres.2025.112129"},{"key":"1449_CR3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2003.03947.x","author":"K Bartlett","year":"2004","unstructured":"Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem. 2004. https:\/\/doi.org\/10.1046\/j.1432-1033.2003.03947.x.","journal-title":"Eur J Biochem"},{"key":"1449_CR4","doi-asserted-by":"publisher","unstructured":"BaslerS, Sievi NA, Schmidt F, Fricke K, Arvaji A, Herth J, et al. Molecular breath profile of acute COPD exacerbations. Journal of breath research. 2024;19(1). https:\/\/doi.org\/10.1088\/1752-7163\/ad9ac4.","DOI":"10.1088\/1752-7163\/ad9ac4"},{"key":"1449_CR5","doi-asserted-by":"publisher","unstructured":"BellantiF, Coda ARD, Trecca MI, Lo Buglio A, Serviddio G, Vendemiale G. Redox imbalance in inflammation: the interplay of oxidative and reductive stress. Antioxidants (Basel). 2025;14(6):656. https:\/\/doi.org\/10.3390\/antiox14060656.","DOI":"10.3390\/antiox14060656"},{"key":"1449_CR6","doi-asserted-by":"publisher","unstructured":"BerryCE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7(5):375\u201382. https:\/\/doi.org\/10.3109\/15412555.2010.510160.","DOI":"10.3109\/15412555.2010.510160"},{"key":"1449_CR7","doi-asserted-by":"publisher","unstructured":"Bialas AJ, Sitarek P, Milkowska-Dymanowska J, Piotrowski WJ, Gorski P. The role of mitochondria and oxidative\/antioxidative imbalance in pathobiology of chronic obstructive pulmonary disease. Oxid Med Cell Longev. 2016;2016:7808576. https:\/\/doi.org\/10.1155\/2016\/7808576.","DOI":"10.1155\/2016\/7808576"},{"key":"1449_CR8","doi-asserted-by":"publisher","unstructured":"Boots AW, Haenen GR, Bast A. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46:14s\u201327s. https:\/\/doi.org\/10.1183\/09031936.03.00000403a.","DOI":"10.1183\/09031936.03.00000403a"},{"key":"1449_CR9","doi-asserted-by":"publisher","unstructured":"Breitzig M, Bhimineni C, Lockey R, Kolliputi N. 4-Hydroxy-2-nonenal: a critical target in oxidative stress? Am J Physiol Cell Physiol. 2016;311(4):C537\u201343. https:\/\/doi.org\/10.1152\/ajpcell.00101.2016.","DOI":"10.1152\/ajpcell.00101.2016"},{"key":"1449_CR10","doi-asserted-by":"publisher","unstructured":"Brinkman P, Ahmed WM, G\u00f3mez C, Knobel HH, Weda H, Vink TJ, et al. Exhaled volatile organic compounds as markers for medication use in asthma. Eur Respir J. 2020;55(2):1900544. https:\/\/doi.org\/10.1183\/13993003.00544-2019.","DOI":"10.1183\/13993003.00544-2019"},{"key":"1449_CR11","doi-asserted-by":"publisher","unstructured":"DevSingh K, Tancev G, Decrue F, Usemann J, Appenzeller R, Barreiro P, et al. Standardization procedures for real-time breath analysis by secondary electrospray ionization high-resolution mass spectrometry. Anal Bioanal Chem. 2019;411:4883\u201398. https:\/\/doi.org\/10.1007\/s00216-019-01764-8.","DOI":"10.1007\/s00216-019-01764-8"},{"key":"1449_CR12","doi-asserted-by":"publisher","unstructured":"Drabi\u0144ska N, Flynn C, Ratcliffe N, Belluomo I, Myridakis A, Gould O, et al. A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome. J Breath Res. 2021;15(3). https:\/\/doi.org\/10.1088\/1752-7163\/abf1d0.","DOI":"10.1088\/1752-7163\/abf1d0"},{"key":"1449_CR13","doi-asserted-by":"publisher","unstructured":"Fairley LH, Das S, Dharwal V, Amorim N, Hegarty KJ, Wadhwa R, et al. Mitochondria-targeted Antioxidants as a Therapeutic strategy for chronic obstructive pulmonary disease. Antioxidants (Basel). 2023;12(4):973. https:\/\/doi.org\/10.3390\/antiox12040973.","DOI":"10.3390\/antiox12040973"},{"key":"1449_CR14","doi-asserted-by":"publisher","unstructured":"Frostegard J. Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation. Expert Rev Clin Immunol. 2022;18(5):525-32. https:\/\/doi.org\/10.1080\/1744666X.2022.2070475.","DOI":"10.1080\/1744666X.2022.2070475"},{"key":"1449_CR15","doi-asserted-by":"publisher","unstructured":"Gaugg MT, Engler A, Nussbaumer-Ochsner Y, Bregy L, Stoberl AS, Gaisl T, et al. Metabolic effects of inhaled salbutamol determined by exhaled breath analysis. Journal of breath research. 2017;11(4):046004. https:\/\/doi.org\/10.1088\/1752-7163\/aa7caa.","DOI":"10.1088\/1752-7163\/aa7caa"},{"key":"1449_CR16","doi-asserted-by":"publisher","unstructured":"Gaugg MT, Nussbaumer-Ochsner Y, Bregy L, Engler A, Stebler N, Gaisl T, et al. Real-time breath analysis reveals specific metabolic signatures of COPD Exacerbations. Chest. 2019;156(2):269\u201376. https:\/\/doi.org\/10.1016\/j.chest.2018.12.023.","DOI":"10.1016\/j.chest.2018.12.023"},{"key":"1449_CR17","doi-asserted-by":"publisher","unstructured":"Gisler A, Singh KD, Zeng J, Osswald M, Awchi M, Decrue F, et al. An interoperability framework for multicentric breath metabolomic studies. iScience. 2022;25(12):10557. https:\/\/doi.org\/10.1016\/j.isci.2022.105557.","DOI":"10.1016\/j.isci.2022.105557"},{"key":"1449_CR18","unstructured":"GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2024 [Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2023\/12\/GOLD-2024_v1.1-1Dec2023_WMV.pdf."},{"key":"1449_CR19","doi-asserted-by":"publisher","unstructured":"Hildreth K, Kodani SD, Hammock BD, Zhao L. Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies. J Nutr Biochem. 2020;86:108484 https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108484.","DOI":"10.1016\/j.jnutbio.2020.108484"},{"key":"1449_CR20","doi-asserted-by":"publisher","unstructured":"Ishizaki T, Ozawa T, Voelkel NF. Leukotoxins and the lung. Pulm Pharmacol Ther. 1999;12(3):145\u201355. https:\/\/doi.org\/10.1006\/pupt.1999.0179.","DOI":"10.1006\/pupt.1999.0179"},{"key":"1449_CR21","doi-asserted-by":"publisher","unstructured":"ItoK, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352(19):1967\u201376. https:\/\/doi.org\/10.1056\/NEJMoa041892.","DOI":"10.1056\/NEJMoa041892"},{"key":"1449_CR22","doi-asserted-by":"publisher","unstructured":"JenR, Rennard SI, Sin DD. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2012;7:587\u201395. https:\/\/doi.org\/10.2147\/COPD.S32765.","DOI":"10.2147\/COPD.S32765"},{"key":"1449_CR23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2664","author":"PA Kirkham","year":"2013","unstructured":"Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013. https:\/\/doi.org\/10.1378\/chest.12-2664.","journal-title":"Chest"},{"key":"1449_CR24","doi-asserted-by":"publisher","unstructured":"Larsson K. Inflammatory markers in COPD. The clinical respiratory journal. 2008;2:84\u20137. https:\/\/doi.org\/10.1111\/j.1752-699X.2008.00089.x.","DOI":"10.1111\/j.1752-699X.2008.00089.x"},{"key":"1449_CR25","doi-asserted-by":"publisher","unstructured":"Lea S, Higham A, Beech A, Singh D. How inhaled corticosteroids target inflammation in COPD. Eur Respir Rev. 2023;32(170):230084. https:\/\/doi.org\/10.1183\/16000617.0084-2023.","DOI":"10.1183\/16000617.0084-2023"},{"key":"1449_CR26","doi-asserted-by":"publisher","unstructured":"Lee W, Thomas PS. Oxidative stress in COPD and its measurement through exhaled breath condensate. Clin Transl Sci. 2009;2(2):150\u20135. https:\/\/doi.org\/10.1111\/j.1752-8062.2009.00093.x.","DOI":"10.1111\/j.1752-8062.2009.00093.x"},{"key":"1449_CR27","doi-asserted-by":"publisher","unstructured":"Lewis BW, Ford ML, Rogers LK, Britt RD, Jr. Oxidative stress promotes corticosteroid insensitivity in asthma and COPD. Antioxidants (Basel). 2021;10(9):1335. https:\/\/doi.org\/10.3390\/antiox10091335.","DOI":"10.3390\/antiox10091335"},{"key":"1449_CR28","doi-asserted-by":"publisher","unstructured":"LipsonDA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378(18):1671\u201380. https:\/\/doi.org\/10.1056\/NEJMoa1713901.","DOI":"10.1056\/NEJMoa1713901"},{"key":"1449_CR29","doi-asserted-by":"publisher","unstructured":"MacNee W. Oxidative stress and chronic obstructive pulmonary disease. https:\/\/doi.org\/10.1183\/1025448x.00038007.","DOI":"10.1183\/1025448x.00038007"},{"key":"1449_CR30","doi-asserted-by":"publisher","unstructured":"Maniscalco M, Candia C, Fuschillo S, Ambrosino P, Paris D, Motta A. Exhaled breath condensate (EBC) in respiratory diseases: recent advances and future perspectives in the age of omic sciences. Journal of breath research. 2024;18(4). https:\/\/doi.org\/10.1088\/1752-7163\/ad7a9a.","DOI":"10.1088\/1752-7163\/ad7a9a"},{"key":"1449_CR31","doi-asserted-by":"publisher","unstructured":"MillerMR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338. https:\/\/doi.org\/10.1183\/09031936.05.00034805.","DOI":"10.1183\/09031936.05.00034805"},{"key":"1449_CR32","doi-asserted-by":"publisher","unstructured":"MitchellJA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, et al. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994;113(3):1008\u201314. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb17093.x.","DOI":"10.1111\/j.1476-5381.1994.tb17093.x"},{"key":"1449_CR33","doi-asserted-by":"publisher","unstructured":"Moura PC, Raposo M, Vassilenko V. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: a review. Biomed J. 2023;46(4):100623. https:\/\/doi.org\/10.1016\/j.bj.2023.100623.","DOI":"10.1016\/j.bj.2023.100623"},{"key":"1449_CR34","doi-asserted-by":"publisher","unstructured":"Munakata M. Exhaled Nitric Oxide (FeNO) as a Non-Invasive Marker of Airway Inflammation. Allergol Int. 2012;61(3):365\u201372. https:\/\/doi.org\/10.2332\/allergolint.12-RAI-0461.","DOI":"10.2332\/allergolint.12-RAI-0461"},{"key":"1449_CR35","doi-asserted-by":"publisher","unstructured":"Mustafina M, Silantyev A, Suvorov A, Chernyak A, Suvorova O, Shmidt A, et al. Integrated exhaled VOC and clinical biomarker profiling for predicting Bronchodilator responsiveness in asthma and COPD patients. Diagnostics. 2025;15(21):2738. https:\/\/doi.org\/10.3390\/diagnostics15212738.","DOI":"10.3390\/diagnostics15212738"},{"key":"1449_CR37","doi-asserted-by":"publisher","unstructured":"Panda L, Gheware A, Rehman R, Yadav MK, Jayaraj BS, Madhunapantula SV, et al. Linoleic acid metabolite leads to steroid resistant asthma features partially through NF-\u03baB. Sci Rep. 2017;7(1):9565. https:\/\/doi.org\/10.1038\/s41598-017-09869-9.","DOI":"10.1038\/s41598-017-09869-9"},{"key":"1449_CR38","doi-asserted-by":"publisher","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388\u201396. https:\/\/doi.org\/10.1093\/nar\/gkab382.","DOI":"10.1093\/nar\/gkab382"},{"key":"1449_CR39","doi-asserted-by":"publisher","unstructured":"Philippova M. Oxidised phospholipids as biomarkers in human disease. Swiss Med Wkly. 2014;144:w14037. https:\/\/doi.org\/10.4414\/smw.2014.14037.","DOI":"10.4414\/smw.2014.14037"},{"key":"1449_CR40","doi-asserted-by":"publisher","unstructured":"PralhadaRao R, Vaidyanathan N, Rengasamy M, Mammen Oommen A, Somaiya N, Jagannath MR. Sphingolipid metabolic pathway: an overview of major roles played in human diseases. J Lipids. 2013;2013:178910. https:\/\/doi.org\/10.1155\/2013\/178910.","DOI":"10.1155\/2013\/178910"},{"key":"1449_CR42","doi-asserted-by":"publisher","unstructured":"Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. European Respiratory Journal. 2006;28(1):219\u201342. https:\/\/doi.org\/10.1183\/09031936.06.00053805.","DOI":"10.1183\/09031936.06.00053805"},{"key":"1449_CR41","doi-asserted-by":"publisher","unstructured":"Rahman I. Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):15\u201329. https:\/\/doi.org\/10.2147\/copd.2006.1.1.15.","DOI":"10.2147\/copd.2006.1.1.15"},{"key":"1449_CR43","doi-asserted-by":"publisher","unstructured":"Schymanski EL, Jeon J, Gulde R, Fenner K, Ruff M, Singer HP, et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol. 2014;48(4):2097\u20138. https:\/\/doi.org\/10.1021\/es5002105.","DOI":"10.1021\/es5002105"},{"key":"1449_CR45","doi-asserted-by":"publisher","unstructured":"Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, et al. Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid\/long-acting beta(2)-agonist: post-hoc analyses of KRONOS. Respir Res. 2025;26(1):175. https:\/\/doi.org\/10.1186\/s12931-025-03234-5.","DOI":"10.1186\/s12931-025-03234-5"},{"key":"1449_CR44","doi-asserted-by":"publisher","unstructured":"SinghKD, Tancev G, Decrue F, Usemann J, Appenzeller R, Barreiro P, et al. Standardization procedures for real-time breath analysis by secondary electrospray ionization high-resolution mass spectrometry. Anal Bioanal Chem. 2019;411(19):4883\u201398. https:\/\/doi.org\/10.1007\/s00216-019-01764-8.","DOI":"10.1007\/s00216-019-01764-8"},{"key":"1449_CR46","doi-asserted-by":"publisher","unstructured":"Spector AA, Kim HY. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta. 2015;1851(4):356\u201365. https:\/\/doi.org\/10.1016\/j.bbalip.2014.07.020.","DOI":"10.1016\/j.bbalip.2014.07.020"},{"key":"1449_CR47","doi-asserted-by":"publisher","unstructured":"Spickett CM. The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis. Redox Biol. 2013;1(1):145\u201352. https:\/\/doi.org\/10.1016\/j.redox.2013.01.007.","DOI":"10.1016\/j.redox.2013.01.007"},{"key":"1449_CR48","doi-asserted-by":"publisher","unstructured":"Storey JD. A direct approach to false discovery rates. J Roy Stat Soc B. 2002;64(3):479\u201398. https:\/\/doi.org\/10.1111\/1467-9868.00346.","DOI":"10.1111\/1467-9868.00346"},{"key":"1449_CR49","doi-asserted-by":"publisher","unstructured":"Tashkin DP, Fabbri LM. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res. 2010;11(1):149. https:\/\/doi.org\/10.1186\/1465-9921-11-149.","DOI":"10.1186\/1465-9921-11-149"},{"key":"1449_CR50","doi-asserted-by":"publisher","unstructured":"TirelliC, Mira S, Belmonte LA, De Filippi F, De Grassi M, Italia M, et al. Exploring the potential role of metabolomics in copd: a concise review. Cells. 2024;13(6):475. https:\/\/doi.org\/10.3390\/cells13060475.","DOI":"10.3390\/cells13060475"},{"key":"1449_CR36","unstructured":"Van Overveld FJ, Demkow UA, Gorecka D, Bialas-Chromiec B, Sadowska AM, Goljan A, et al. The effects of N-acetylcysteine and inhaled steroid on inflammatory and oxidative stress markers in chronic obstructive pulmonary disease (COPD). Centr Eur J Immunol. 2008;33(3):135\u201341."},{"key":"1449_CR51","doi-asserted-by":"publisher","unstructured":"Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993\u20131013. https:\/\/doi.org\/10.1183\/09031936.00082507.","DOI":"10.1183\/09031936.00082507"},{"key":"1449_CR52","doi-asserted-by":"publisher","unstructured":"Wallace MAG, Pleil JD. Evolution of clinical and environmental health applications of exhaled breath research: review of methods and instrumentation for gas-phase, condensate, and aerosols. Anal Chim Acta. 2018;1024:18\u201338. https:\/\/doi.org\/10.1016\/j.aca.2018.01.069.","DOI":"10.1016\/j.aca.2018.01.069"},{"key":"1449_CR53","doi-asserted-by":"publisher","unstructured":"Wechsler ME, Wells JM. What every clinician should know about inflammation in COPD. ERJ Open Res. 2024;10(5):00177\u20132024. https:\/\/doi.org\/10.1183\/23120541.00177-2024.","DOI":"10.1183\/23120541.00177-2024"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01449-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01449-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:25:46Z","timestamp":1775647546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01449-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01449-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the cantonal ethics committee of Zurich (BASEC-Nr. 2021\u201300539) and adhered to the principles of the Declaration of Helsinki and Good Clinical Practice. The study was registered at ClinicalTrials.gov (NCT05458934) and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}